Skip to content
Menu
  • Home
  • About Us
  • Learn
    • About Alkaptonuria
    • AKU Treatment
    • AKU Publications
  • Patients
    • Worldwide Map
    • Testimonials
    • Clinical Trials
  • Links & Resources
  • News
  • Donate
  • Contact Us

Nitisinone approved by the European Commission!

Posted on October 30, 2020 by Denise Higgins

The AKU Society in the UK is incredibly proud to announce that the European Commission (EC) has extended the existing marketing authorisation for nitisinone use in AKU. This is the culmination of years of hard work and dedication.

“We hope this decision means that patients across Europe will now begin to be able to access nitisinone. With this step, AKU no longer becomes a life sentence to pain and disability. We will continue to fight for patients’ access to the drug, across Europe and beyond. Thank you to everyone who has helped us reach this huge milestone. ”

Read the EC’s decision HERE.

RECENT POSTS

  • Rare Disease Day – 28 February
  • 10th Anniversary of the National Alkaptonuria Centre UK
  • Radio Interview with Denise Higgins on Handi-Link Radio
  • AKU: A Rare Story of Hope
  • Nitisinone approved by the European Commission!

[See All Posts]

501(c)(3) pending • EIN #27-5527376

The AKU Society of North America
6352 Corte del Abeto Ste B Carlsbad, CA 92011

©2023 | Powered by WordPress & Superb Themes